- Home
- SYM vs DYN Comparison
SYM vs DYN Comparison
Compare SYM & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYM
- DYN
- Stock Information
- Founded
- SYM 2005
- DYN 1984
- Country
- SYM United States
- DYN United States
- Employees
- SYM N/A
- DYN N/A
- Industry
- SYM Industrial Machinery/Components
- DYN Medicinal Chemicals and Botanical Products
- Sector
- SYM Industrials
- DYN Health Care
- Exchange
- SYM Nasdaq
- DYN Nasdaq
- Market Cap
- SYM 3.0B
- DYN 2.6B
- IPO Year
- SYM N/A
- DYN 2020
- Fundamental
- Price
- SYM $25.06
- DYN $25.97
- Analyst Decision
- SYM Buy
- DYN Strong Buy
- Analyst Count
- SYM 13
- DYN 11
- Target Price
- SYM $42.50
- DYN $51.18
- AVG Volume (30 Days)
- SYM 4.4M
- DYN 836.3K
- Earning Date
- SYM 02-03-2025
- DYN 11-12-2024
- Dividend Yield
- SYM N/A
- DYN N/A
- EPS Growth
- SYM N/A
- DYN N/A
- EPS
- SYM N/A
- DYN N/A
- Revenue
- SYM $1,788,179,000.00
- DYN N/A
- Revenue This Year
- SYM $31.75
- DYN N/A
- Revenue Next Year
- SYM $32.00
- DYN N/A
- P/E Ratio
- SYM N/A
- DYN N/A
- Revenue Growth
- SYM 51.94
- DYN N/A
- 52 Week Low
- SYM $17.11
- DYN $11.66
- 52 Week High
- SYM $58.28
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- SYM 40.02
- DYN 38.55
- Support Level
- SYM $25.28
- DYN $25.27
- Resistance Level
- SYM $27.45
- DYN $28.96
- Average True Range (ATR)
- SYM 2.14
- DYN 1.41
- MACD
- SYM -0.40
- DYN -0.23
- Stochastic Oscillator
- SYM 27.50
- DYN 14.25
About SYM Symbotic Inc.
Symbotic Inc is an automation technology company that develops technologies to improve operating efficiencies in modern warehouses. The group develops, commercializes, and deploys innovative, end-to-end technology solutions that dramatically improve supply chain operations. Symbotic also automates the processing of pallets and cases in large warehouses or distribution centers for some of the retail and wholesale companies in the world. The company operates in two geographical regions the United States and Canada. Key revenue is generated from the United States.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.